The easy choice
Managing feline diabetes might feel overwhelming at first — but it doesn’t have to be.
SENVELGO® (velagliflozin oral solution) is a once-daily, liquid oral treatment that helps many cat owners like you care for your cats with confidence and ease. In fact, a study showed that 89.1% of cats achieved successful outcomes with SENVELGO®.¹
Once-a-day and on your way
With once-daily dosing that takes the hassle out of treatment, you and your cat can get back to what you love most — from cozy cuddles to carefree cat naps.
SENVELGO®
(velagliflozin oral solution)
The benefits of SENVELGO®:
-
Once-daily dosing1
-
Convenient liquid formula
-
Well-accepted by cats2
-
Easy & accurate dosing
-
No refrigeration required1
-
Needle-free oral solution
Why Choose SENVELGO® oral solution?
-
Easy to administer
Can be given with a small amount of wet food or directly into your cat’s mouth. Prevents the need for needles and twice-daily insulin injections in most diabetic cats.
-
Works fast
SENVELGO® oral solution works fast, making an impact on your cat’s diabetes in as soon as 7 days.1
-
Trusted by vets
This state-of-the-art treatment is endorsed by top veterinary diabetes experts.2
Success Stories From Owners Like You
Cat owners share the unique experiences of their cat's diabetes diagnosis and treatment with SENVELGO® oral solution.
Education Hub
Explore essential resources on diabetes in cats, diabetic ketoacidosis (DKA), and treatment approaches.
Is Your Cat at Risk for Diabetes?
Important Safety Information
SENVELGO® (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin.
Before using this product, it is important to read the entire product insert, including the boxed warning.
Cats treated with SENVELGO® may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death.
Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO®.
Do not use SENVELGO® in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus.
The use of SENVELGO® in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO®, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.
Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO® should prompt immediate discontinuation of SENVELGO® and assessment for diabetic ketoacidosis, regardless of blood glucose level.
SENVELGO® should not be initiated in cats with ketonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis.
Keep SENVELGO® in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose.
For more information, please see full prescribing information.